Imatinib associated temporal bone osteonecrosis
Clinical Case Reports · 2023-07 · 11 (7)
DOI: 10.1002/ccr3.7611 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 28.06.2023. Verfasst von Dominic McKenna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Craigavon Area Hospital (Southern Health and Social Care Trust) Portadown UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Clinical Message Tyrosine kinase inhibitors have substantially improved survival in patients with gastrointestinal stromal tumors (GIST) and chronic myeloid leukemia (CML). We report the first association between long‐term imatinib use and temporal bone osteonecrosis, highlighting the importance of prompt ENT evaluation of such patients with new otological symptoms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Craigavon Area Hospital (Southern Health and Social Care Trust) Portadown UK.
ORCID-Profile: Dominic McKenna
Zitieren
APA
McKenna, D., & Reddy, E. (2023). Imatinib associated temporal bone osteonecrosis. Clinical Case Reports, 11(7). https://doi.org/10.1002/ccr3.7611
Vancouver
McKenna D, Reddy E. Imatinib associated temporal bone osteonecrosis. Clinical Case Reports. 2023;11(7). doi:10.1002/ccr3.7611
BibTeX
@article{McKenna2023,
author = {McKenna, Dominic and Reddy, Ekambar},
title = {Imatinib associated temporal bone osteonecrosis},
journal = {Clinical Case Reports},
year = {2023},
volume = {11},
number = {7},
doi = {10.1002/ccr3.7611}
}
EUVIMED